View in EDS

Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.

Saved in:
Bibliographic Details
Title: Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Authors: Lloyd KA; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Parsons BN; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Burkitt MD; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Moore AR; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom., Papoutsopoulou S; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Boyce M; Trio Medicines, Ltd, Hammersmith Medicines Research, London, United Kingdom., Duckworth CA; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Exarchou K; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom., Howes N; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom., Rainbow L; Centre for Genomic Research, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Fang Y; Centre for Genomic Research, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Oxvig C; Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark., Dodd S; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Varro A; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Hall N; Centre for Genomic Research, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom; The Earlham Institute, Norwich, Norfolk, United Kingdom; School of Biological Sciences, University of East Anglia, Norwich, Norfolk, United Kingdom., Pritchard DM; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom. Electronic address: mark.pritchard@liv.ac.uk.
Source: Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2020; Vol. 10 (1), pp. 113-132. Date of Electronic Publication: 2020 Jan 28.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Gastroenterological Association Country of Publication: United States NLM ID: 101648302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-345X (Electronic) Linking ISSN: 2352345X NLM ISO Abbreviation: Cell Mol Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32004755
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lloyd+KA%22">Lloyd KA</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Parsons+BN%22">Parsons BN</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burkitt+MD%22">Burkitt MD</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moore+AR%22">Moore AR</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Papoutsopoulou+S%22">Papoutsopoulou S</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Boyce+M%22">Boyce M</searchLink>; Trio Medicines, Ltd, Hammersmith Medicines Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Duckworth+CA%22">Duckworth CA</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Exarchou+K%22">Exarchou K</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Howes+N%22">Howes N</searchLink>; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rainbow+L%22">Rainbow L</searchLink>; Centre for Genomic Research, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fang+Y%22">Fang Y</searchLink>; Centre for Genomic Research, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Oxvig+C%22">Oxvig C</searchLink>; Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.<br /><searchLink fieldCode="AU" term="%22Dodd+S%22">Dodd S</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Varro+A%22">Varro A</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hall+N%22">Hall N</searchLink>; Centre for Genomic Research, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom; The Earlham Institute, Norwich, Norfolk, United Kingdom; School of Biological Sciences, University of East Anglia, Norwich, Norfolk, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pritchard+DM%22">Pritchard DM</searchLink>; Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool University Hospitals, National Health Service Foundation Trust, Liverpool, United Kingdom. Electronic address: mark.pritchard@liv.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648302%22">Cellular and molecular gastroenterology and hepatology</searchLink> [Cell Mol Gastroenterol Hepatol] 2020; Vol. 10 (1), pp. 113-132. <i>Date of Electronic Publication: </i>2020 Jan 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Gastroenterological+Association%22">American Gastroenterological Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101648302 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-345X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222352345X%22">2352345X </searchLink><i>NLM ISO Abbreviation: </i>Cell Mol Gastroenterol Hepatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32004755
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jcmgh.2020.01.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 113
    Titles:
      – TitleFull: Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lloyd KA
      – PersonEntity:
          Name:
            NameFull: Parsons BN
      – PersonEntity:
          Name:
            NameFull: Burkitt MD
      – PersonEntity:
          Name:
            NameFull: Moore AR
      – PersonEntity:
          Name:
            NameFull: Papoutsopoulou S
      – PersonEntity:
          Name:
            NameFull: Boyce M
      – PersonEntity:
          Name:
            NameFull: Duckworth CA
      – PersonEntity:
          Name:
            NameFull: Exarchou K
      – PersonEntity:
          Name:
            NameFull: Howes N
      – PersonEntity:
          Name:
            NameFull: Rainbow L
      – PersonEntity:
          Name:
            NameFull: Fang Y
      – PersonEntity:
          Name:
            NameFull: Oxvig C
      – PersonEntity:
          Name:
            NameFull: Dodd S
      – PersonEntity:
          Name:
            NameFull: Varro A
      – PersonEntity:
          Name:
            NameFull: Hall N
      – PersonEntity:
          Name:
            NameFull: Pritchard DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2352-345X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cellular and molecular gastroenterology and hepatology
              Type: main
ResultId 1